SCHEMBL2047269

SCHEMBL2047269

CCCCCCCCCCCCCCCCOc1ccccc1C(=O)O

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.74
▸ MEN1 O00255 2/20 0.74
▸ LMNA P02545 2/20 0.74
▸ CYP3A4 P08684 2/20 0.74
▸ NR1I2 O75469 1/20 0.74
▸ CHRM2 P08172 1/20 0.74
▸ ADRA2A P08913 1/20 0.74
▸ MAPT P10636 1/20 0.74
▸ OPRK1 P41145 1/20 0.74
▸ HTR2B P41595 1/20 0.74
▸ SLC6A3 Q01959 1/20 0.74
▸ HDAC6 Q9UBN7 1/20 0.74
▸ PTPN11 Q06124 6/20 0.68
▸ ALDH1A1 P00352 4/20 0.65
▸ PTK2B Q14289 1/20 0.65
▸ NPSR1 Q6W5P4 1/20 0.62
▸ KDM4E B2RXH2 1/20 0.60
▸ RECQL P46063 1/20 0.60
▸ PTPN1 P18031 3/20 0.60
▸ S1PR3 Q99500 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1274781 1.00 KMT2A (0.74) KMT2AMEN1LMNACYP3A4NR1I2
SCHEMBL6575990 1.00 KMT2A (0.74) KMT2AMEN1LMNACYP3A4NR1I2
SCHEMBL18140779 1.00 KMT2A (0.74) KMT2AMEN1LMNACYP3A4NR1I2
SCHEMBL1005992 1.00 KMT2A (0.74) KMT2AMEN1LMNACYP3A4NR1I2
SCHEMBL2044840 1.00 KMT2A (0.74) KMT2AMEN1LMNACYP3A4NR1I2
SCHEMBL8859205 1.00 KMT2A (0.74) KMT2AMEN1LMNACYP3A4NR1I2
SCHEMBL6688170 1.00 KMT2A (0.74) KMT2AMEN1LMNACYP3A4NR1I2
SCHEMBL342176 1.00 KMT2A (0.74) KMT2AMEN1LMNACYP3A4NR1I2
SCHEMBL2550439 1.00 KMT2A (0.74) KMT2AMEN1LMNACYP3A4NR1I2
SCHEMBL18141371 1.00 KMT2A (0.74) KMT2AMEN1LMNACYP3A4NR1I2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 195 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250099369-A1 TOPICAL DELIVERY COMPOSITIONS COMPRISING NON-STEROIDAL ANTI-INFLAMMATORY DRUGS ANDROS PHARMACEUTICALS CO., LTD. (TW) 2025-03-27 — — US claimed
CN-115851337-B Preparation method of alkaline calcium alkyl salicylate 新乡市瑞丰新材料股份有限公司 2023-12-22 — — CN claimed
CN-117050034-A Multifunctional benzothiadiazole Schiff base luminescent liquid crystal and preparation and application thereof 云南大学 2023-11-14 — — CN claimed
CN-115851337-A Preparation method of alkaline calcium alkyl salicylate 新乡市瑞丰新材料股份有限公司 2023-03-28 — — CN claimed
CN-111234208-B Polyester/polyamide copolymer and preparation method and application thereof 中山大学 2021-07-16 — — CN claimed
CN-111691217-A Method for recovering free starch in papermaking white water 瑞辰星生物技术(广州)有限公司 2020-09-22 — — CN claimed
CN-111234208-A Polyester/polyamide copolymer and preparation method and application thereof 中山大学 2020-06-05 — — CN claimed
CN-104031701-B A kind of low-sulfur diesel-oil lubrication anti-wear agent 陕西省石油化工研究设计院 2016-10-19 — — CN claimed
WO-2012129683-A1 EXTRACTS FROM PLANTS OF THE TSUGA GENUS AND USES THEREOF IN THE TREATMENT OF SKIN DISORDERS BIOPHARMACOPAE DESIGN INTERNATIONAL INC. (CA) 2012-10-04 — — WO claimed
EP-0987011-B1 Cosmetic and/or dermatological composition containing salicylic acid or its derivatives and its use OREAL (FR) 2002-07-17 — — EP claimed
US-6143301-A Chromium picolinate compositions and uses thereof AMBI INC. (US) 2000-11-07 — — US claimed
US-20250099369-A1 TOPICAL DELIVERY COMPOSITIONS COMPRISING NON-STEROIDAL ANTI-INFLAMMATORY DRUGS ANDROS PHARMACEUTICALS CO., LTD. (TW) 2025-03-27 — — US disclosed
CN-115851337-B Preparation method of alkaline calcium alkyl salicylate 新乡市瑞丰新材料股份有限公司 2023-12-22 — — CN disclosed
CN-117050034-A Multifunctional benzothiadiazole Schiff base luminescent liquid crystal and preparation and application thereof 云南大学 2023-11-14 — — CN disclosed
US-20230205083-A1 SALT COMPOUND, RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-06-29 — — US disclosed
US-4739041-A DEGRADATION AND ETHER-FORMING ON PHENOLIC SITES TEXACO INC. (US) 1988-04-19 — — US disclosed
US-4434062-A Oil displacement enhanced by lyotropic liquid crystals in highly saline media EXXON RESEARCH AND ENGINEERING CO. (US) 1984-02-28 — — US disclosed
US-4130702-A Polyacryloylaminobenzoic acid, polymethacryloylaminobenzoic acid and method of preparation CELANESE CORPORATION (US) 1978-12-19 — — US disclosed
US-4087284-A Color-developer coating for use in copy systems CHAMPION INTERNATIONAL CORPORATION (US) 1978-05-02 — — US disclosed
US-3995097-A Prevention of fouling in polymerization reactors PHILLIPS PETROLEUM COMPANY (US) 1976-11-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230205083-A1 SALT COMPOUND, RESIST COMPOSITION AND PATTERNING PROCESS SLC6A9, SLC6A5, REN KMT2A 2175/4885MEN1 3242/4885LMNA 2393/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback